Iqra Mumal, MSc,  —

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

Articles by Iqra Mumal

Diabetes Therapy Could Be Used to Treat Alzheimer’s, Study Reports

An approved treatment for diabetes may help people with Alzheimer’s, a study reports. The research, “Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer’s disease,” was published in the journal Brain Research. Many scientists have tried without success to develop Alzheimer’s…

First Participants Dosed in a Phase 1 Clinical Trial of COR388

The pharmaceutical company Cortexyme announced that the first group of participants has been dosed in the Phase 1 clinical trial of its lead compound, COR388, for the treatment of Alzheimer’s disease. Because no new successful developments have emerged in Alzheimer’s therapeutics in the last 15 years, researchers have been trying…